Last modified: Friday, February 10, 2006
With addition of "HOG," IUETC's portfolio of cancer research grows
FOR IMMEDIATE RELEASE
Feb. 10, 2006
BLOOMINGTON, Ind. -- The Hoosier Oncology Group LLC, a Walther Cancer Institute subsidiary, is moving its offices to the Indiana University Emerging Technologies Center.
The HOG, as its members affectionately call it, is a non-profit, contract research organization comprising 400 cancer physicians, researchers and nurses in the greater Midwest region. It was founded in 1985 by IU Cancer Center faculty and Indianapolis-area oncologists who desired to increase cancer patients' access to clinical trials.
"Moving into the IUETC will allow us to establish relationships with new strategic partners as we position our organization to better service our customers and develop new business," said HOG Chairman Christopher Sweeney. "At the same time, we are grateful to the Walther Cancer Institute as this move furthers the Walther mission of enhancing collaborations. It is a logistical step that will allow HOG to increase its support of cancer research across the IU, Purdue and Notre Dame campuses as well as further our role in the life sciences efforts throughout Indiana."
The HOG is currently coordinating clinical trials involving treatments for a dozen different ailments including breast, prostate, colorectal and lung cancers. Doctors co-administering the trials are located in Indiana, Massachusetts, Michigan and several other states.
"The Hoosier Oncology Group is a key alliance for Clarian Health Partners and the IU School of Medicine, as it has a strong track record of managing cancer clinical trials," said IUETC President and CEO Mark Long. "HOG fits the life sciences profile of a start-up company involved in a high-growth sector."
On March 1, the IUETC will celebrate its third birthday. This weekend, Long will discuss the anniversary, HOG's arrival and other successes on Gerry Dick's "Inside Indiana Business" (WTHR-TV 13, Sunday, Feb. 12, at 11 a.m.).